As more individuals face health risks associated with excess weight, the demand for GLP-1 receptor agonist, proven to reduce weight, improve glycemic control and lower cardiometabolic risk, is expected to rise substantially, thereby driving the growth of the GLP-1 receptor agonist market
Of the two peptides only OXM was found to stimulate insulin secretion but its potency was too low to be of clinical benefit (Holst 2024
Many patients with diabetes have overlapping cardiovascular and renal complications that require coordinated treatment strategies
conducted a randomized controlled trial in obese older adults with cardiovascular or metabolic conditions, comparing three intervention groups: caloric restriction alone (WL), caloric restriction combined with aerobic training (WL + AT), and caloric restriction combined with resistance training (WL + RT)
NASH is the progressive form of NAFLD, characterized by hepatocyte death and hepatic inflammation
The detection window extends approximately 714 days post-administration, depending on dose and individual metabolism
